Orphanet Journal of Rare Diseases has recently published an article quantifying the benefit-risk preferences for new medicines in rare disease patients and… Read more »
Ségolène is Editor-in-chief of Orphanet Journal of Rare Diseases.
Latest posts by Segolene Ayme (see all)
- Benefits and risks preferences for new medicines in rare diseases - 27th May 2016
- If rare diseases are so rare, why do they matter? - 29th February 2016